Source recordFED

Centre for Commercialization of Cancer Immunotherapy

Federal grants & contributions· Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives· National Research Council Canada· FY2022· $674,412· BN 787733690· QC

Description

This Project aims at establishing a current Good Manufacturing Practices (cGMP)-compliant platform to manufacture clinical grade lentiviral vectors (including production, purification and quality control) at the Centre of Excellence for Cel…

Amendment chain · 4 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $1,000,000 at start, $674,412 after amendment #3 (−$325,588).

$1,000,000$0Original · 2021-04-01 (start date) · total $1,000,000Amendment 1 · 2022-06-20 · total $1,000,000Amendment 2 · 2023-05-10 · total $1,000,000Amendment 3 · 2024-12-17 · total $674,412
  • #02021-04-01$1,000,000
  • #12022-06-20$1,000,000
  • #22023-05-10$1,000,000
  • #32024-12-17$674,412-$325,588
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2021-04-01(start date)$1,000,000—This Project aims at establishing a current Good Manufacturing Practices (cGMP)-compliant platform to manufact…
#1 amendment2022-06-20$1,000,000+$0This Project aims at establishing a current Good Manufacturing Practices (cGMP)-compliant platform to manufact…
#2 amendment2023-05-10$1,000,000+$0This Project aims at establishing a current Good Manufacturing Practices (cGMP)-compliant platform to manufact…
#3 amendment2024-12-17$674,412−$325,588This Project aims at establishing a current Good Manufacturing Practices (cGMP)-compliant platform to manufact…

Related records · 8

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 787733690)

RefDepartment · programCurrent valueFY
093-2023-2024-Q3-00033Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · The Regional Economic Growth Through Innovation Program (REGI)$2,500,000FY2024
093-2024-2025-Q4-00032Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · The Regional Economic Growth Through Innovation Program (REGI)$3,000,000FY2024
093-2025-2026-Q2-00213Canada Economic Development for Quebec Regions | Développement économique Canada pour les régions du Québec · The Regional Economic Growth Through Innovation Program (REGI)$3,000,000FY2024

Other recipients funded under "Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2026-2027-Q1-1044103York UniversityFY2027$462,000FY2027
172-2026-2027-Q1-1043787Simon Fraser UniversityFY2027$279,766FY2027
172-2026-2027-Q1-1044229Noram Electrolysis Systems Inc.FY2027$300,053FY2027
172-2026-2027-Q1-1043305University of OttawaFY2027$418,000FY2027
172-2026-2027-Q1-1043602University of WindsorFY2027$99,000FY2027

Cite as: Glassbox record view · Federal grants & contributions · 172-2021-2022-Q1-972253 · retrieved 2026-11-15.